(Press-News.org) In a study of an all-oral drug regimen, a majority of volunteers with liver damage due to hepatitis C virus (HCV) infection were cured following a six-month course of therapy that combined an experimental drug, sofosbuvir, with the licensed antiviral drug ribavirin. The results showed that the regimen was highly effective in clearing the virus and well tolerated in a group of patients who historically have had unfavorable prognoses.
Scientists from the National Institute of Allergy and Infectious Diseases (NIAID) and the NIH Clinical Center, parts of the National Institutes of Health, led the Phase II trial. The findings appear in the Aug. 28 issue of the Journal of the American Medical Association (JAMA).
More than 3 million Americans have chronic HCV infection, a condition that is a major cause of cirrhosis (liver tissue scarring) and liver cancer, and a leading reason for liver transplantation. Deaths from HCV-related liver disease number about 15,000 every year. Standard treatment for HCV can last up to a year and usually involves weekly injections of pegylated interferon-alpha given with the oral drug ribavirin and an HCV protease inhibitor. Side effects from this treatment can be severe, notably from interferon-alpha, and can include depression, flu-like symptoms and anemia.
"There is a pressing need for hepatitis C virus treatments that are less burdensome to the patient, have fewer side effects and take less time to complete. Building on previous work, this trial provides compelling evidence that interferon-free regimens can be safe and effective," said NIAID Director and study co-author Anthony S. Fauci, M.D.
The current study involved 60 volunteers with genotype-1 HCV, which tends to be less responsive to interferon-based treatment. Fifty of the 60 participants were African-American.
"While African-Americans make up about 13 percent of the U.S. population, they represent more than 22 percent of people with chronic HCV infection and, compared to whites, have lower cure rates with traditional HCV therapy," said NIAID researcher Shyam Kottilil, M.D., Ph.D., the principal investigator of the trial. "Several recently completed trials testing interferon-free regimens have yielded promising results, but most volunteers in those studies were white."
The new study also differs from many previous trials because it enrolled people with severe liver damage as well as those with mild or moderately scarred livers.
The study was divided into two parts. The first part enrolled 10 people with mild or moderate liver fibrosis. Volunteers received oral ribavirin at a dosage based on their weight along with the experimental drug sofosbuvir, also in pill form, taken daily for six months. Gilead Sciences, Inc., of Foster City, Calif., manufactures sofosbuvir and supplied it to the study physicians.
Nine volunteers completed the course of therapy. Virus was undetectable in all nine volunteers 12 weeks after the end of therapy and continued undetectable when they were tested again 24 weeks after finishing therapy. HCV does not integrate itself into human DNA. If the virus cannot be detected for a period of 12 weeks after stopping therapy, the patient is considered cured, Dr. Kottilil said.
The second part of the trial enrolled 50 volunteers, 13 of whom had liver damage rated as serious. Twenty-five received ribavirin based on their weight, and 25 received a low dose (600 milligrams per day). All received sofosbuvir.
"Because ribavirin can cause serious side effects, including anemia, we wanted to compare response rates in patients taking low-dose ribavirin with results from patients on a weight-based dosage," said Dr. Kottilil.
At four, 12 and 24 weeks after the end of treatment, volunteers were tested for the presence of HCV. HCV levels were undetectable in 24 of the volunteers in the weight-based arm when treatment ended. Of those, 17 continued to have undetectable virus levels 24 weeks later and were considered cured of infection. In the low-dose arm, three volunteers dropped out of the study. Of the remaining 22, all responded to the treatment, but only 12 were considered cured at 24 weeks after the end of treatment.
"We saw an overall cure rate of about 70 percent using regimens that did not include interferon," said Dr. Kottilil. "This is an encouraging result, especially considering the proportion of volunteers who had characteristics—such as being male, having HCV genotype-1 infection, being African-American and having advanced liver damage—that are recognized as predictors of poor response to treatment."
Additional trials are underway to further determine if regimens without interferon or ribavirin can help people with chronic HCV infection, particularly those who have both HIV and HCV infections, said Dr. Kottilil. These trials include two studies in which volunteers with or without HIV infection take a combination of HCV drugs (but no interferon or ribavirin) for periods of three months or less. Information about these trials is available at clinicaltrials.gov using the identifiers NCT01805882 and NCT01878799.
###
Further information about the HCV trial described in the current issue of JAMA is available at clinicaltrials.gov using the trial identifier NCT01441180.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website at http://www.niaid.nih.gov.
About the National Institutes of Health (NIH):
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.
NIH...Turning Discovery Into Health
Reference:
A Osinusi et al. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: A randomized clinical trial. JAMA DOI: 10.1001/JAMA.2013.109309 (2013).
Investigational oral regimen for hepatitis C shows promise in NIH trial
Side effects minimized with combination therapy in hard-to-treat patients
2013-08-28
ELSE PRESS RELEASES FROM THIS DATE:
Frontiers news briefs: Aug. 26
2013-08-28
Frontiers in Psychology
Interesting and useful musings are associated with a happy mood
Mind wandering can be a sign of mental wellbeing, provided that your off-task musings are interesting and useful even if not related to the task at hand, finds a new study in Frontiers in Psychology.
The negative effects of mind wandering on performance and mood have recently received much attention, for example in the much-publicized study A wandering mind is an unhappy mind (Science 2010, 330:932). But Michael S. Franklin and colleagues here use a similar but more detailed experimental ...
Mayo Clinic: High-tech imaging contributing to overdiagnosis of low-risk thyroid cancers
2013-08-28
ROCHESTER, Minn. -- An increasing gap between the incidence of thyroid cancer and deaths from the disease suggests that low-risk cancers are being overdiagnosed and overtreated, a study from the Mayo Clinic Center for the Science of Health Care Delivery finds. The study appears in the current issue of the British Medical Journal.
"High tech imaging technologies such as ultrasound, CT and MRI can detect very small thyroid nodules many of which are slow growing papillary thyroid cancers, says the study's lead author Juan Pablo Brito, M.B.B.S. an endocrine fellow and health ...
European hunter-gatherers owned pigs as early as 4600 BC
2013-08-28
European hunter-gatherers acquired domesticated pigs from nearby farmers as early as 4600BC, according to new evidence.
The international team of scientists, including researchers at Durham and Aberdeen universities, showed there was interaction between the hunter-gatherer and farming communities and a 'sharing' of animals and knowledge. The interaction between the two groups eventually led to the hunter-gatherers incorporating farming and breeding of livestock into their culture, say the scientists.
The research, published in Nature Communications today (27 August), ...
New surgical tool may help sleep apnea sufferers, Wayne State research finds
2013-08-28
DETROIT — A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome (OSAHS).
Ho-Sheng Lin, M.D., a fellow with the American College of Surgeons and professor of otolaryngology-head and neck surgery in the School of Medicine and Karmanos Cancer Institute, reported promising results in the July issue of The Laryngoscope, for treating sleep apnea using transoral robotic surgery (TORS), a technique whose safety and tolerability have recently been established for removing ...
Contagious savings
2013-08-28
A commercial health insurer's large scale demonstration program designed to improve quality and lower costs for subscribers also lowered costs for Medicare patients who used the same health care providers but were not covered by the plan.
"These findings suggest that provider groups are willing—and able—to make systemic changes that result in higher-value care for patients across the board," said author J. Michael McWilliams, assistant professor of health care policy and medicine at Harvard Medical School and a practicing general internist at Brigham and Women's Hospital.
The ...
Control scheme dynamically maintains unstable quantum system
2013-08-28
A simple pendulum has two equilibrium points: hanging in the "down" position and perfectly inverted in the "up" position. While the "down" position is a stable equilibrium, the inverted position is definitely not stable. Any infinitesimal deviation from perfectly inverted is enough to cause the pendulum to eventually swing down.
It has been known for more than 100 years, though, that an inverted pendulum can be stabilized by vibrating the pivot point. This non-intuitive phenomenon is known as dynamic stabilization, and it has led to a broad range of applications including ...
Winter depression not as common as many think, OSU research shows
2013-08-28
CORVALLIS, Ore. – New research suggests that getting depressed when it's cold and dreary outside may not be as common as is often believed.
In a study recently published online in the Journal of Affective Disorders, researchers found that neither time of year nor weather conditions influenced depressive symptoms. However, lead author David Kerr of Oregon State University said this study does not negate the existence of clinically diagnosed seasonal affective disorder, also known as SAD, but instead shows that people may be overestimating the impact that seasons have on ...
UTHealth, Swedish researchers uncover mystery in blood clotting disorder
2013-08-28
HOUSTON – (Aug. 27, 2013) – Fifteen years ago, a hematologist came to Dianna Milewicz, M.D., Ph.D., with a puzzle: Multiple generations of an East Texas family suffered from a moderately severe bleeding disorder, but it wasn't hemophilia.
"No surgeon would do elective surgery because they bled too much after surgery," said Milewicz, professor and director of the Division of Medical Genetics at The University of Texas Health Science Center at Houston (UTHealth). "So we collected DNA and plasma from the family and were able to determine that a genetic variant in the Factor ...
University of Tennessee lecturer investigates response to 'bad' art
2013-08-28
An oil painting of a piece of wood with a sad face sitting on the ground or a pink pony with Disney Princess-like hair. Would people come to like these pieces, considered "bad art" by some websites, if they became more familiar with them?
This was a question asked by an international team of scholars including a University of Tennessee, Knoxville, philosophy lecturer.
Websites like Tumblr catalogue pieces of what are deemed "bad art." However, a well-accepted phenomenon called the "mere exposure effect"—supported by the works of psychologist James Cutting, among others—suggests ...
Fractions gain traction with concrete models
2013-08-28
This news release is available in French.
Montreal, August 27, 2013 — If 3 is greater than 2, then ⅓ must be bigger than ½ — right? Wrong. As thousands of students head back to school, many will use exactly that kind of thinking when faced with fractions for the first time. New research from Concordia University shows that for children to understand math, teachers must constantly make the connection between abstract numbers and real world examples.
Helena Osana, associate professor in Concordia's Department of Education, and PhD candidate Nicole Pitsolantis ...
LAST 30 PRESS RELEASES:
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
Association of state cannabis legalization with cannabis use disorder and cannabis poisoning
Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders
Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals
Unlocking the mysteries of the human gut
High-quality nanodiamonds for bioimaging and quantum sensing applications
New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
[Press-News.org] Investigational oral regimen for hepatitis C shows promise in NIH trialSide effects minimized with combination therapy in hard-to-treat patients